Dual orexin/hypocretin receptor antagonism attenuates attentional impairments in an NMDA receptor hypofunction model of schizophrenia
E. B. Maness, S. A. Blumenthal, J. A. Burk
This study shows that dual orexin receptor antagonism reduces attentional impairments caused by NMDA receptor hypofunction in a rat model of schizophrenia.
bioRxiv · Feb 5, 2023 · PreprintAnimal Behavior & Cognition